About us Specialties Products SICCS developments News Contact Customer access Cre8 EVO Cre8 ™ EVO is a drug-eluting stent designed to meet the challenges of coronary lesions in patients who have to undergo angioplasty intervention. BIS, BioInducer Surface. The entire stent is covered with pure carbon atoms that favor the rapid coating of the prosthesis after implantation and seal the entire surface avoiding possible detachment of metal ions. ART technology (Abluminal Reservoir Technology) Thanks to the reservoirs dug in the straight stent segments, it is possible to guarantee an effective drug concentration within the wall of the coronary vessel, including difficult coronary anatomy and complex pathologies. Amphilimus Formula: Cre8EVO is the only DES on the market that releases a complete formula, Amphilimus (it does not only release an active principle), which provides a greater efficacy of the drug compared to other devices on the market. Its components, sirolimus and an organic acid, facilitate cellular absorption in cases of complex and very common diseases such as diabetes or obesity. Related products: Headquarters: Av. Corts Catalanes 8 Floor 3 Sant Cugat del Valles - 08173 Barcelona Quality politics Contact: info@biomenco.com T. 936 67 65 55 Utilizamos cookies para asegurar que damos la mejor experiencia al usuario en nuestra web. Si sigues utilizando este sitio asumiremos que estás de acuerdo.Estoy de acuerdo

About us Specialties Products SICCS developments News Contact Customer access Excimer Laser Technology Innovation: the only way to improve results Excimer laser technology recognizes each type of catheter: Coronary Laser Peripheral Endovascular Laser Electrode Removal Related products: Headquarters: Av. Corts Catalanes 8 Floor 3 Sant Cugat del Valles - 08173 Barcelona Quality politics Contact: info@biomenco.com T. 936 67 65 55 We use cookies to ensure that we give the best user experience on our website. If you continue to use this site we will assume that you agree.I agree

About us Specialties Products SICCS developments News Contact Customer access Category Without category WITHOUT CATEGORY November 10, 2021 Interview with Dr. Rafael Romaguera. The SUGAR Trial. Amphilimus-versus zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease. At… Biomenco 0 0 WITHOUT CATEGORY October 1, 2021 V DAY OF EXTRACTION OF CARDIAC STIMULATION DEVICES. Everything prepared for the V edition of STIMULATION DEVICES EXTRACTION DAYS ... Biomenco 0 0 WITHOUT CATEGORY October 1, 2021 5th MEETING CHRONIC OCLUSIONS OMG COURSE BARCELONA Biomenco will participate again in the 5th Meeting of Chronic Occlusions that takes place in ... Biomenco 0 0 Headquarters: Av. Corts Catalanes 8 Floor 3 Sant Cugat del Valles - 08173 Barcelona Quality politics Contact: info@biomenco.com T. 936 67 65 55 We use cookies to ensure that we give the best user experience on our website. If you continue to use this site we will assume that you agree.I agree